Comments

Regulus Therapeutics

RGLSNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.78
0.021.14%
At Close: -
$1.84
0.063.37%
After Hours: Jul 26, 4:36 PM EDT
15 minutes delayed
Regulus Therapeutics (RGLS) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$2.00
Consensus Price Target1
$9.50

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Regulus Therapeutics (NASDAQ:RGLS) Stock, Analyst Ratings, Price Targets, Forecasts

Regulus Therapeutics Inc has a consensus price target of $9.5 based on the ratings of 6 analysts. The high is $28 issued by Canaccord Genuity on June 25, 2024. The low is $2 issued by Cantor Fitzgerald on September 2, 2021. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co. on July 16, 2024, June 25, 2024, and June 25, 2024, respectively. With an average price target of $16 between HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co., there's an implied 769.57% upside for Regulus Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
Mar
0
0
0
0
May
0
0
0
0
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Canaccord Genuity
Jones Trading
Leerink Partners
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for Regulus Therapeutics

Buy NowGet Alert
07/16/2024Buy Now443.48%HC Wainwright & Co.
Raghuram Selvaraju
$10 → $10ReiteratesBuy → BuyGet Alert
06/25/2024Buy Now1421.74%Canaccord Genuity
Whitney Ijem
$11 → $28MaintainsBuyGet Alert
06/25/2024Buy Now443.48%HC Wainwright & Co.
Raghuram Selvaraju
$9 → $10MaintainsBuyGet Alert
05/31/2024Buy Now334.78%Jones Trading
Catherine Novack
 → $8Initiates → BuyGet Alert
05/10/2024Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
05/06/2024Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
03/25/2024Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
03/19/2024Buy Now497.83%Canaccord Genuity
Whitney Ijem
$12 → $11MaintainsBuyGet Alert
03/18/2024Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now226.09%Leerink Partners
Joseph Schwartz
 → $6Initiates → OutperformGet Alert
03/13/2024Buy Now63.04%Wells Fargo
Jim Birchenough
$2 → $3MaintainsEqual-WeightGet Alert
09/21/2023Buy Now552.17%Canaccord Genuity
Whitney Ijem
$9 → $12MaintainsBuyGet Alert
09/21/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
09/19/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
08/10/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
06/28/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
05/15/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
 → $9ReiteratesBuy → BuyGet Alert
04/21/2023Buy Now389.13%HC Wainwright & Co.
Raghuram Selvaraju
$20 → $9MaintainsBuyGet Alert
11/08/2022Buy Now389.13%Canaccord Genuity
Whitney Ijem
 → $9Initiates → BuyGet Alert
09/02/2021Buy Now8.7%Cantor Fitzgerald
Brian Cheng
—Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Regulus Therapeutics (RGLS) stock?

A

The latest price target for Regulus Therapeutics (NASDAQ:RGLS) was reported by HC Wainwright & Co. on July 16, 2024. The analyst firm set a price target for $10.00 expecting RGLS to rise to within 12 months (a possible 443.48% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Regulus Therapeutics (RGLS)?

A

The latest analyst rating for Regulus Therapeutics (NASDAQ:RGLS) was provided by HC Wainwright & Co., and Regulus Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Regulus Therapeutics (RGLS)?

A

There is no last upgrade for Regulus Therapeutics

Q

When was the last downgrade for Regulus Therapeutics (RGLS)?

A

There is no last downgrade for Regulus Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Regulus Therapeutics (RGLS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Regulus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Regulus Therapeutics was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.

Q

Is the Analyst Rating Regulus Therapeutics (RGLS) correct?

A

While ratings are subjective and will change, the latest Regulus Therapeutics (RGLS) rating was a reiterated with a price target of $10.00 to $10.00. The current price Regulus Therapeutics (RGLS) is trading at is $1.84, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch